Senior Vice President, Clinical Development Services & Global Head of Neuroscience
Krista Armstrong has held leadership roles for Project Management and Operations delivery at Premier Research and now oversees the Neuroscience Business Unit. This Business Unit includes Premier’s most experienced Neuroscience clinical research professionals for psychiatric and neurological indications to ensure that the Premier team provides sponsors with the best possible regulatory and scientific, medical and operational delivery advice. Dr. Armstrong’s primary therapeutic and operational expertise has had a specific emphasis on psychiatric indications such as ADHD, schizophrenia, mood disorders, ASD, eating disorders, substance use disorders and PTSD as well as neurological conditions such as Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, epilepsy and stroke.
But that’s only part of the story.
“Premier’s focus is not just therapeutically aligned. Our teams are keenly aware of the requirements necessary to partner with the innovative biotech sector and provide a tailored, high-touch program delivery approach that offers ownership and accountability that drives successful study and business objectives for our sponsors. For example, a large majority of our sponsors start with just one asset. The culture and strategy around the development of a single asset and need to be flexible and responsive to ensure the greatest probability of conclusive results is at the heart of our operational delivery model. Our sponsors are often focused in areas of unmet or under-served medical need where the success of their product would dramatically improve the lives of those affected by their disease. The importance of this type of drug development cannot be over-stated.”
“For me, being able to offer a potentially better treatment option for patients is an exciting and rewarding career.”
Dr. Armstrong’s clinical research experience spans more than 20 years in both academia and the pharmaceutical industry. At Premier Research, she led the integration of six acquisitions and grew the clinical operations department from 60 to more than 500 employees globally.
Dr. Armstrong received her doctorate in neuroscience from the University of Florida.